149 related articles for article (PubMed ID: 28889382)
1. Urothelial Carcinoma Stem Cells: Current Concepts, Controversies, and Methods.
Hatina J; Parmar HS; Kripnerova M; Hepburn A; Heer R
Methods Mol Biol; 2018; 1655():121-136. PubMed ID: 28889382
[TBL] [Abstract][Full Text] [Related]
2. [Markers of stem cells and their prognostic values for urothelial carcinomas of the urinary tract].
Osmanov YI; Kogan EA; Rapoport LM; Teodorovich OV; Gaibov JA
Urologiia; 2019 Jun; (2):40-49. PubMed ID: 31162900
[TBL] [Abstract][Full Text] [Related]
3. Urothelial Cancer Stem Cell Heterogeneity.
Kripnerova M; Parmar HS; Pesta M; Kohoutova M; Kuncova J; Drbal K; Rajtmajerova M; Hatina J
Adv Exp Med Biol; 2019; 1139():127-151. PubMed ID: 31134499
[TBL] [Abstract][Full Text] [Related]
4. Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines.
Skowron MA; Niegisch G; Fritz G; Arent T; van Roermund JG; Romano A; Albers P; Schulz WA; Hoffmann MJ
J Exp Clin Cancer Res; 2015 Nov; 34():144. PubMed ID: 26606927
[TBL] [Abstract][Full Text] [Related]
5. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
[TBL] [Abstract][Full Text] [Related]
6. The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers.
Hoggarth ZE; Osowski DB; Freeberg BA; Garrett SH; Sens DA; Sens MA; Zhou XD; Zhang KK; Somji S
PLoS One; 2018; 13(12):e0207877. PubMed ID: 30550540
[TBL] [Abstract][Full Text] [Related]
7. GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.
Inoue R; Hirohashi Y; Kitamura H; Nishida S; Murai A; Takaya A; Yamamoto E; Matsuki M; Tanaka T; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Sato N; Masumori N; Torigoe T
Oncotarget; 2017 Apr; 8(17):28826-28839. PubMed ID: 28418868
[TBL] [Abstract][Full Text] [Related]
8. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.
Garg M
Cancer Metastasis Rev; 2015 Dec; 34(4):691-701. PubMed ID: 26328525
[TBL] [Abstract][Full Text] [Related]
9. Stem cells in the biology of normal urothelium and urothelial carcinoma.
Hatina J; Schulz WA
Neoplasma; 2012; 59(6):728-36. PubMed ID: 22862174
[TBL] [Abstract][Full Text] [Related]
10. Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma.
Mai KT; Busca A; Belanger EC
Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):505-512. PubMed ID: 26990746
[TBL] [Abstract][Full Text] [Related]
11. Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells.
Gehlot P; Shukla V; Gupta S; Makidon PE
J Transl Med; 2016 Feb; 14():49. PubMed ID: 26873175
[TBL] [Abstract][Full Text] [Related]
12. Molecular aspects of upper tract urothelial carcinoma.
Patel N; Arya M; Muneer A; Powles T; Sullivan M; Hines J; Kelly J
Urol Oncol; 2014 Jan; 32(1):28.e11-20. PubMed ID: 23428541
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
14. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
[TBL] [Abstract][Full Text] [Related]
15. Bladder cancer stem cells.
Tran MN; Goodwin Jinesh G; McConkey DJ; Kamat AM
Curr Stem Cell Res Ther; 2010 Dec; 5(4):387-95. PubMed ID: 20955163
[TBL] [Abstract][Full Text] [Related]
16. Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.
Ooki A; Begum A; Marchionni L; VandenBussche CJ; Mao S; Kates M; Hoque MO
Int J Cancer; 2018 Jul; 143(1):113-126. PubMed ID: 29396848
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
18. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
19. Isolation of cancer progenitor cells from cancer stem cells in gastric cancer.
Shang Z; Xu Y; Liang W; Liang K; Hu X; Wang L; Zou Z; Ma Y
Mol Med Rep; 2017 Jun; 15(6):3637-3643. PubMed ID: 28393208
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of CD133
Nair RM; Balla MM; Khan I; Kalathur RKR; Kondaiah P; Vemuganti GK
BMC Cancer; 2017 Nov; 17(1):779. PubMed ID: 29162051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
